What Are the Different Types of Continuous Glucose Monitoring (CGM) Systems in the United States? and How Do I Choose One?

• Abbott. Abbott Research centers, which was founded in 1888, has the most experience with CGM devices.
• Dexcom.
• Eversense.
• Medtronic.
• Abbott's FreeStyle Libre.

Continuous glucose monitoring (CGM) devices help you manage Type 1 or Type 2 diabetes with fewer fingerstick tests. A sensor just under your skin measures your glucose levels 24 hours a day. A transmitter sends results to a wearable device or cell phone.

CGM costs range from $100 to $300 per month, depending on the brand and the pharmacy, says Dr. Guerra. The cost typically covers the sensors (the part of the CGM inserted in the body) and transmitters (the part of the CGM visible on the body).

With approximately 2.4 million CGM users domestically, according to a 2021 market analysis by Seagrove Partners, the adoption rate across all diabetes types is comparatively low. However, up to 70% of CGM use is for type 1 diabetes (T1D); only 3-4% of the U.S. T2D population use CGM despite established benefits.

(NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA has cleared the next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all Types of diabetes ages two years and older.

Top suppliers for CGM

• Abbott is the manufacturer of the Freestyle Libre 14-Day System and The FreeStyle Libre 2.
• The FreeStyle Libre 2 was approved by the FDA in 2020 and is Abbott's first CGM system approved for children as young as 4 years old.
• Dexcom was the second company to have its CGM approved by the FDA.

CGMs continually monitor your blood glucose (blood sugar), giving you real-time updates through a device that is attached to your body. They have become popular and more accurate over the years and are now considered a viable treatment option for people with diabetes.

Unlike a single reading from a blood glucose meter, a CGM provides real-time, dynamic information about the speed and direction (trending higher or lower) of your glucose levels. Having continuous feedback on diet, exercise, and insulin requirements from a CGM can help you make more informed treatment decisions.

How big is the continuous glucose monitoring device market? b. The global CGM devices market size was estimated at USD 7.8 billion in 2022 and is expected to reach USD 8.3 billion in 2023.

FreeStyle Libre What is the cheapest CGM? The least expensive CGM without insurance by far is the FreeStyle Libre products.

Amid the COVID-19 crisis, the United States Continuous Glucose Monitoring (CGM) was valued at $2,830 Million in 2021 and is expected to grow at a CAGR of 11.5% in the forecast period, to reach $6,000 Million by 2028.

The global CGM devices market size was estimated at USD 7.8 billion in 2022 and is expected to reach USD 8.3 billion in 2023.

In 1999, the U.S. Food and Drug Administration approved the first “professional” CGM, with which the patient was blinded to glucose data collected for 3 days, and then the information was downloaded in the health care provider's office for review.

Here are four of the best CGM devices we think are worth your consideration.

• 1) Best for Overall Function: Dexcom G6.
• 2) Best for Overall Value: Abbott FreeStyle Libre.
• 3) Best for Adaptive Technology: Medtronic Guardian 3.
• 4) Best for Low-Maintenance Monitoring: Senseonics Eversense.

In September 2016, the U.S. Food and Drug Administration (FDA) approved the Freestyle Libre Pro Glucose Monitoring System, a continuous glucose monitoring (CGM) system for blinded professional use in clinics.

Use of CGM resulted in a dramatic and significant reduction in both HbA1c and mean glucose. There were highly significant improvements in five measures of hypoglycemia, (LBGI, %GRADEhypoglycemia, and percentage of time glucose was ≤2.8, ≤3.3, or ≤3.9 mM (≤50, ≤60, or ≤70 mg/dL)).